Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population
Abstract Background Lenvatinib is a multitargeted tyrosine kinase inhibitor that is being tested in combination with immune checkpoint inhibitors to treat advanced gastric cancer; however, little data exists regarding the efficacy of lenvatinib monotherapy. Patient-derived xenografts (PDX) are estab...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2022-03-01
|
| Serier: | Journal of Translational Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12967-022-03317-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
